
Dinesh Ballbhdas Kothari
About Dinesh Ballbhdas Kothari
Data last updated:
Dinesh Ballbhdas Kothari is a Managing Director at Serum Biotec Limited (since 1997), Director at Dawabag Private Limited (since 2019) and Director at Nootan Pharmaceutical Private Limited (since 2019). The companies operate in Pharma and Chemicals. The largest current company by reported revenue is Serum Biotec Limited at ₹3.54 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 24 Oct 1997 | 1997 | ₹3.54 Cr (FY 2024) | Active | |
| Director | 06 Nov 2019 | 2019 | Active | ||
| Director | 13 Aug 2019 | 2019 | Active |
Board colleagues of Dinesh Ballbhdas Kothari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Lata Dinesh Kothari | 01769346 | Serum Biotec Limited , Dawabag Private Limited and 1 more | Director |
| Revati Dinesh Kothari | 08589025 | Serum Biotec Limited , Dawabag Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dinesh Ballbhdas Kothari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dinesh Ballbhdas Kothari
Dinesh Ballbhdas Kothari currently holds 3 directorships: Serum Biotec Limited (Managing Director, since 24 Oct 1997, revenue ₹3.54 Cr (FY 2024)); Dawabag Private Limited (Director, since 06 Nov 2019); Nootan Pharmaceutical Private Limited (Director, since 13 Aug 2019).
Dinesh Ballbhdas Kothari was first appointed on 24 Oct 1997 as Managing Director at Serum Biotec Limited. The most recent appointment on record is 06 Nov 2019 at Dawabag Private Limited.
The current boards of Dinesh Ballbhdas Kothari's companies include Lata Dinesh Kothari (Serum Biotec Limited), Revati Dinesh Kothari (Serum Biotec Limited).